Melpomeni Peppa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Melpomeni Peppa has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Sotirios A. Raptis
11 shared publicationsDimitrios Hadjidakis
8 shared publicationsTheofanis Economopoulos
8 shared publicationsEleni Boutati
5 shared publicationsChrysi Koliaki
4 shared publicationsVasilios Pikounis
4 shared publications
Latest Publications
- 1 December 2013
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 24 (8) , 824-831
Regional fat distribution and cardiometabolic risk in healthy postmenopausal women
- 1 December 2013
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 24 (8) , 824-831
Regional fat distribution and cardiometabolic risk in healthy postmenopausal women
- Open Access
Association of lean body mass with cardiometabolic risk factors in healthy postmenopausal women
Objective: Aim of this study was to investigate the association of total and regional lean body mass (LBM) with cardiometabolic risk factors in healthy obese and nonobese postmenopausal women.Methods: A total of 150 postmenopausal women (age 54 ± 7 years, BMI 29.6 ± 5.8 kg/m2) underwent a comprehensive assessment of cardiometabolic risk, including metabolic syndrome (MS). Body composition analysis was performed with Dual‐energy X‐ray Absorptiometry, and multiple height‐adjusted indices of total and regional LBM were evaluated.Results: After controlling for age, diet, physical activity, and total fat mass, most indices of total, central, and peripheral LBM displayed significant positive correlations with cardiometabolic risk factors. Most associations were no longer significant after controlling for waist circumference, with the only exception of lean mass in the arms, which remained significantly associated with the presence and severity of MS (number of MS abnormalities), independently of central adiposity. A significant additive interaction was found between lean mass in the arms and waist circumference in increasing the prevalence of MS.Conclusions: LBM is unfavorably associated with cardiometabolic risk factors in healthy postmenopausal women. Whether LBM, especially in arms, is associated with cardiometabolic health independently of central fat distribution in postmenopausal women, merits further investigation.
Open AccessAssociation of lean body mass with cardiometabolic risk factors in healthy postmenopausal women
Objective: Aim of this study was to investigate the association of total and regional lean body mass (LBM) with cardiometabolic risk factors in healthy obese and nonobese postmenopausal women.Methods: A total of 150 postmenopausal women (age 54 ± 7 years, BMI 29.6 ± 5.8 kg/m2) underwent a comprehensive assessment of cardiometabolic risk, including metabolic syndrome (MS). Body composition analysis was performed with Dual‐energy X‐ray Absorptiometry, and multiple height‐adjusted indices of total and regional LBM were evaluated.Results: After controlling for age, diet, physical activity, and total fat mass, most indices of total, central, and peripheral LBM displayed significant positive correlations with cardiometabolic risk factors. Most associations were no longer significant after controlling for waist circumference, with the only exception of lean mass in the arms, which remained significantly associated with the presence and severity of MS (number of MS abnormalities), independently of central adiposity. A significant additive interaction was found between lean mass in the arms and waist circumference in increasing the prevalence of MS.Conclusions: LBM is unfavorably associated with cardiometabolic risk factors in healthy postmenopausal women. Whether LBM, especially in arms, is associated with cardiometabolic health independently of central fat distribution in postmenopausal women, merits further investigation.
- 1 November 2011
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 7 (6) , 416-425
Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship
Impaired diabetic wound healing (WH) constitutes a serious diabetic complication with increased morbidity, mortality and health expenditure. The exact pathogenetic mechanisms have not been fully clarified. A variety of hyperglycemia and oxidative stress related factors, have been proposed, including advanced glycaction end products (AGE). The existing literature data, support the role of AGE in the pathogenesis of diabetic complications, namely micro- and macro- angiopathy which underlie delayed diabetic WH. In addition, a large body of evidence support a direct negative effect of AGE in the WH process by their interference with various components involved in the cascade following skin injury. Endogenously formed or exogenously derived AGE, in a similar manner, affect negatively the WH process in diabetes. It is obvious that further studies are needed to clarify the exact role of AGE in the impaired diabetic WH and offer possible new therapeutic strategies
- 1 November 2011
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 7 (6) , 416-425
Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship
Impaired diabetic wound healing (WH) constitutes a serious diabetic complication with increased morbidity, mortality and health expenditure. The exact pathogenetic mechanisms have not been fully clarified. A variety of hyperglycemia and oxidative stress related factors, have been proposed, including advanced glycaction end products (AGE). The existing literature data, support the role of AGE in the pathogenesis of diabetic complications, namely micro- and macro- angiopathy which underlie delayed diabetic WH. In addition, a large body of evidence support a direct negative effect of AGE in the WH process by their interference with various components involved in the cascade following skin injury. Endogenously formed or exogenously derived AGE, in a similar manner, affect negatively the WH process in diabetes. It is obvious that further studies are needed to clarify the exact role of AGE in the impaired diabetic WH and offer possible new therapeutic strategies
- Open Access
- 18 July 2011
- Published by Hindawi Limited in Journal of Lipids
- Vol. 2011, 1-9
Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease
Dyslipidemia is a common finding in patients with thyroid disease, explained by the adverse effects of thyroid hormones in almost all steps of lipid metabolism. Not only overt but also subclinical hypo- and hyperthyroidism, through different mechanisms, are associated with lipid alterations, mainly concerning total and LDL cholesterol and less often HDL cholesterol, triglycerides, lipoprotein (a), apolipoprotein A1, and apolipoprotein B. In addition to quantitative, qualitative alterations of lipids have been also reported, including atherogenic and oxidized LDL and HDL particles. In thyroid disease, dyslipidemia coexists with various metabolic abnormalities and induce insulin resistance and oxidative stress via a vice-vicious cycle. The above associations in combination with the thyroid hormone induced hemodynamic alterations, might explain the increased risk of coronary artery disease, cerebral ischemia risk, and angina pectoris in older, and possibly ischemic stroke in younger patients with overt or subclinical hyperthyroidism.
- 18 July 2011
- Published by Hindawi Limited in Journal of Lipids
- Vol. 2011, 1-9
Open AccessLipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease
Dyslipidemia is a common finding in patients with thyroid disease, explained by the adverse effects of thyroid hormones in almost all steps of lipid metabolism. Not only overt but also subclinical hypo- and hyperthyroidism, through different mechanisms, are associated with lipid alterations, mainly concerning total and LDL cholesterol and less often HDL cholesterol, triglycerides, lipoprotein (a), apolipoprotein A1, and apolipoprotein B. In addition to quantitative, qualitative alterations of lipids have been also reported, including atherogenic and oxidized LDL and HDL particles. In thyroid disease, dyslipidemia coexists with various metabolic abnormalities and induce insulin resistance and oxidative stress via a vice-vicious cycle. The above associations in combination with the thyroid hormone induced hemodynamic alterations, might explain the increased risk of coronary artery disease, cerebral ischemia risk, and angina pectoris in older, and possibly ischemic stroke in younger patients with overt or subclinical hyperthyroidism.
- Open Access
- 1 March 2011
- Published by Taylor & Francis in Integrated Blood Pressure Control
- Vol. 4, 7-16
Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review
Peer reviewed article authored by (Melpomeni Peppa, Maria Krania, Sotirios A Raptis). Read article or submit your manuscript for publishing.
- 1 March 2011
- Published by Taylor & Francis in Integrated Blood Pressure Control
- Vol. 4, 7-16
Open AccessHypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review
Peer reviewed article authored by (Melpomeni Peppa, Maria Krania, Sotirios A Raptis). Read article or submit your manuscript for publishing.
- 22 October 2010
- Published by Wiley in Journal of Internal Medicine
- Vol. 268 (6) , 555-566
Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications
Abstract. Peppa M, Koliaki C, Raptis SA (Athens University Medical School, Attikon University Hospital, Haidari, Athens; Hellenic National Diabetes Center for the Prevention, Research and Treatment of Diabetes Mellitus and its Complications (H.N.D.C), Athens, Greece). Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications (Review). J Intern Med 2010; 268: 555–566.Adrenal incidentalomas (AIs) represent adrenal masses that are incidentally discovered whilst investigating symptoms and signs unrelated to adrenal pathology. The onset and natural course of AIs are unknown, and the possible underlying cardiometabolic abnormalities have not been examined in depth. A growing body of clinical and experimental evidence supports the notion that both functioning and, paradoxically, nonfunctioning AIs are associated with a partially expressed or even full‐blown metabolic syndrome (MS) phenotype, through yet unclear mechanisms. Subtle, subclinical or even profound adrenal hormone excess and an increased proinflammatory state might explain to some extent the development of MS disturbances. The emerging association between AIs and MS appears to be important in determining the optimal clinical management of these patients and raises speculation about the exact mechanisms of this interesting cause–effect relationship.
- 22 October 2010
- Published by Wiley in Journal of Internal Medicine
- Vol. 268 (6) , 555-566
Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications
Abstract. Peppa M, Koliaki C, Raptis SA (Athens University Medical School, Attikon University Hospital, Haidari, Athens; Hellenic National Diabetes Center for the Prevention, Research and Treatment of Diabetes Mellitus and its Complications (H.N.D.C), Athens, Greece). Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications (Review). J Intern Med 2010; 268: 555–566.Adrenal incidentalomas (AIs) represent adrenal masses that are incidentally discovered whilst investigating symptoms and signs unrelated to adrenal pathology. The onset and natural course of AIs are unknown, and the possible underlying cardiometabolic abnormalities have not been examined in depth. A growing body of clinical and experimental evidence supports the notion that both functioning and, paradoxically, nonfunctioning AIs are associated with a partially expressed or even full‐blown metabolic syndrome (MS) phenotype, through yet unclear mechanisms. Subtle, subclinical or even profound adrenal hormone excess and an increased proinflammatory state might explain to some extent the development of MS disturbances. The emerging association between AIs and MS appears to be important in determining the optimal clinical management of these patients and raises speculation about the exact mechanisms of this interesting cause–effect relationship.
- 1 October 2010
- Published by Elsevier in Metabolism
- Vol. 59 (10) , 1435-1441
Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
- 1 October 2010
- Published by Elsevier in Metabolism
- Vol. 59 (10) , 1435-1441
Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
- 1 July 2010
- Published by Elsevier in Endocrine Practice
- Vol. 16 (4) , 641-645
Large Adrenal Oncocytoma with Uncertain Malignant Potential: Case Report and Review of Literature
- 1 July 2010
- Published by Elsevier in Endocrine Practice
- Vol. 16 (4) , 641-645
Large Adrenal Oncocytoma with Uncertain Malignant Potential: Case Report and Review of Literature
- Open Access
- 15 March 2010
- Published by Hindawi Limited in Journal of Biomedicine and Biotechnology
- Vol. 2010, 1-13
Skeletal Muscle Insulin Resistance in Endocrine Disease
We summarize the existing literature data concerning the involvement of skeletal muscle (SM) in whole body glucose homeostasis and the contribution of SM insulin resistance (IR) to the metabolic derangements observed in several endocrine disorders, including polycystic ovary syndrome (PCOS), adrenal disorders and thyroid function abnormalities. IR in PCOS is associated with a unique postbinding defect in insulin receptor signaling in general and in SM in particular, due to a complex interaction between genetic and environmental factors. Adrenal hormone excess is also associated with disrupted insulin action in peripheral tissues, such as SM. Furthermore, both hyper- and hypothyroidism are thought to be insulin resistant states, due to insulin receptor and postreceptor defects. Further studies are definitely needed in order to unravel the underlying pathogenetic mechanisms. In summary, the principal mechanisms involved in muscle IR in the endocrine diseases reviewed herein include abnormal phosphorylation of insulin signaling proteins, altered muscle fiber composition, reduced transcapillary insulin delivery, decreased glycogen synthesis, and impaired mitochondrial oxidative metabolism.
- 15 March 2010
- Published by Hindawi Limited in Journal of Biomedicine and Biotechnology
- Vol. 2010, 1-13
Open AccessSkeletal Muscle Insulin Resistance in Endocrine Disease
We summarize the existing literature data concerning the involvement of skeletal muscle (SM) in whole body glucose homeostasis and the contribution of SM insulin resistance (IR) to the metabolic derangements observed in several endocrine disorders, including polycystic ovary syndrome (PCOS), adrenal disorders and thyroid function abnormalities. IR in PCOS is associated with a unique postbinding defect in insulin receptor signaling in general and in SM in particular, due to a complex interaction between genetic and environmental factors. Adrenal hormone excess is also associated with disrupted insulin action in peripheral tissues, such as SM. Furthermore, both hyper- and hypothyroidism are thought to be insulin resistant states, due to insulin receptor and postreceptor defects. Further studies are definitely needed in order to unravel the underlying pathogenetic mechanisms. In summary, the principal mechanisms involved in muscle IR in the endocrine diseases reviewed herein include abnormal phosphorylation of insulin signaling proteins, altered muscle fiber composition, reduced transcapillary insulin delivery, decreased glycogen synthesis, and impaired mitochondrial oxidative metabolism.
- 1 November 2009
- Published by Elsevier in Clinical Breast Cancer
- Vol. 9 (4) , E4-E7
Panhypopituitarism due to Metastases to the Hypothalamus and the Pituitary Resulting From Primary Breast Cancer: A Case Report and Review of the Literature
- 1 November 2009
- Published by Elsevier in Clinical Breast Cancer
- Vol. 9 (4) , E4-E7
Panhypopituitarism due to Metastases to the Hypothalamus and the Pituitary Resulting From Primary Breast Cancer: A Case Report and Review of the Literature